<?xml version="1.0" encoding="UTF-8"?>
<oembed>
  <version>1.0</version>
  <type>link</type>
  <title>Pharma Pharmacovigilance, Medical Affairs &amp; Regulatory Submission Lines (China) — COO Agent Operations | ANDYGROVE.SYSTEMS</title>
  <author_name>ANDYGROVE.SYSTEMS Continuing Professional Development &amp; Operations Research Collective</author_name>
  <author_url>https://andygrove.systems/education</author_url>
  <provider_name>ANDYGROVE.SYSTEMS — High Output Operations &amp; Fresh Preprints Upskilling Hub</provider_name>
  <provider_url>https://andygrove.systems</provider_url>
  <cache_age>86400</cache_age>
  <thumbnail_url>https://andygrove.systems/og-card.png</thumbnail_url>
  <thumbnail_width>1200</thumbnail_width>
  <thumbnail_height>630</thumbnail_height>
  <url>https://andygrove.systems/china/coo-pharma-pharmacovigilance-regulatory</url>
  <description>Pharma Pharmacovigilance, Medical Affairs &amp; Regulatory Submission Lines in China (GxP / 21 CFR Part 11 / 7- &amp; 15-Day ICSR Adverse Event Reporting). Governing COO law: 100% L1 Medical Reviewer Gate on Serious ICSRs + Halfin–Whitt Surge Pods. Request a scoped 1-Page Agent Line Audit or engage $20–45/hr IE/OR pods (Tsinghua University (Dept. of Industrial Engineering), Shanghai Jiao Tong University (SJTU IE &amp; Management), Zhejiang University, HuazhongUST, Xi&apos;an Jiao Tong, Beihang, Tongji, USTC). | Fresh Preprints: https://andygrove.systems/preprints | 42-Hr CPD Hub: https://andygrove.systems/education (Independent; not affiliated with Intel Corporation or the Grove family)</description>
</oembed>